TMH (The Medical House) sells non-core SQ-PEN needle-free insulin
This article was originally published in Clinica
Executive Summary
UK medical technology company The Medical House (TMH) has sold its SQ-PEN needle-free insulin injector business to Dutch company Diabetes Management International (DMI) for up to £810,000 ($1.6m), which includes £60,000 for inventory held by TMH.